Day after mass FDA firings, new commissioner addresses remaining staff, focusing on 'MAHA' vision

Zachary Brennan

Senior Editor

New FDA Commissioner Marty Makary took to the stage at the regulator’s Maryland headquarters on Wednesday, in his first public communication to much of the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Day after mass FDA firings, new commissioner addresses remaining staff, focusing on 'MAHA' vision

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

Caribou lays off 32% of staff, cuts lupus cell therapy program before first patient

New fund will pressure flailing biotechs, as investor frustration boils over

Paul Stoffels on retiring from Galapagos; Boehringer Ingelheim switches up leadership

Merck KGaA closes in on SpringWorks deal at $3.5B price point

AbbVie's immunology franchise remains a powerhouse, as Skyrizi, Rinvoq combine for $5B

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

Day af­ter mass FDA fir­ings, new com­mis­sion­er ad­dress­es re­main­ing staff, fo­cus­ing on 'MA­HA' vi­sion

Senior Editor

Sign up to read this article for free.

Gondolabio

Palo Alto, CA, USA

Day after mass FDA firings, new commissioner addresses remaining staff, focusing on 'MAHA' vision